Mankind Pharma Ltd Cash Flow Quality Index
Mankind Pharma Ltd cash flow quality index. Mankind Pharma Ltd (MANKIND) has a Cash Flow Quality Index of 1.72x as of September 2025. Operating cash flow of Rs16.37 Billion exceeds net income of Rs9.50 Billion, indicating high earnings quality where cash backs reported profits. See MANKIND financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Mankind Pharma Ltd (2019–2026)
Cash flow quality index of Mankind Pharma Ltd from 2019 to 2026. Historical Cash Flow Quality Index for Mankind Pharma Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Mankind Pharma Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Mankind Pharma Ltd Cash Flow Quality Index by Year (2019–2026)
Mankind Pharma Ltd cash flow quality index by year from 2019 to 2026. Year-by-year earnings quality comparison for Mankind Pharma Ltd. For the full cash flow conversion analysis, see how efficiently does Mankind Pharma Ltd generate cash.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 1.32x | Rs25.16 Billion | Rs19.13 Billion | ▲ +8.5% |
| 2025 | 1.21x | Rs24.13 Billion | Rs19.91 Billion | ▲ +7.7% |
| 2024 | 1.13x | Rs21.52 Billion | Rs19.13 Billion | ▼ -20.5% |
| 2023 | 1.41x | Rs18.13 Billion | Rs12.82 Billion | ▲ +203.7% |
| 2022 | 0.47x | Rs9.20 Billion | Rs19.75 Billion | ▼ -30.7% |
| 2021 | 0.67x | Rs11.37 Billion | Rs16.92 Billion | ▼ -9.6% |
| 2020 | 0.74x | Rs10.70 Billion | Rs14.38 Billion | ▼ -28.3% |
| 2019 | 1.04x | Rs6.00 Billion | Rs5.79 Billion | — |